Clinical trial
Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel…
NCT00366431 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00366431 |
|---|---|
| Title | Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Non-Malignant Pain |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Constipation |
| Intervention type | Drug |
| Interventions | MOA-728 |
| Enrollment | 420 |
| Start date | Aug 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Aug 21, 2006 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: